Venous thromboembolism risk, prophylaxis and management in cancer patients with COVID-19: An unmet medical need
Cancer patients exhibit an increased risk of venous thromboembolism (VTE), with VTE being the second leading cause of morbidity and mortality in these patients. The implementation of lockdowns following the COVID-19 pandemic has resulted in decreased mobility and delayed access to care, thus further...
Main Authors: | Benjamin Brenner, Cihan Ay, Grégoire Le Gal, Marc Carrier, Andrés J. Muñoz, Giancarlo Agnelli, Ana Thereza Cavalcanti Rocha, Hikmat Abdel-Razeq, Ismail Elalamy, Anna Falanga |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-03-01
|
Series: | Thrombosis Update |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666572722000025 |
Similar Items
-
Primary Thromboprophylaxis for the Prevention of Venous Thromboembolism in Cancer Patients with Central Venous Catheters: A Literature Review
by: Hikmat Abdel-Razeq, et al.
Published: (2024-03-01) -
Venous thromboembolic complications in lymphoma patients
by: Otašević Vladimir, et al.
Published: (2020-01-01) -
Venous Thromboembolism Prophylaxis in Major Orthopedic Surgeries and Factor XIa Inhibitors
by: Aaryana Jones, et al.
Published: (2023-08-01) -
Intermittent pneumatic compression is a cost-effective method of orthopedic postsurgical venous thromboembolism prophylaxis
by: Saunders R, et al.
Published: (2018-04-01) -
A Cross-sectional Study of the Assessment of Venous Thromboembolism Risk and Use of Anticoagulant Thromboprophylaxis
by: Emile Abimana, et al.
Published: (2022-03-01)